Skip to content

Chemed CHE Segment Vitas — Interest Income Expense Net

Other segment segments

Segment Roto Rooter
$4.32M+14.8%

Similar metrics at other companies

JAN
JANSegments Total — Interest Income Expense Nonoperating Net
-$967K-234%
JAN
JANTotal Reportable Segments — Interest Income Expense Nonoperating Net
-$688.5K-254%
IPG Photonics logo
IPGPReportable Segment — Interest income, net
$6.92M-7.0%
Immunovant, Inc. logo
IMVTReportable Segment — Interest Income (Expense), Nonoperating
$8.06M+17.0%
Globus Medical logo
GMEDReportable Segment — Interest income/(expense), net
$5.43M+223%
Starwood Property Trust logo
STWDInvesting and Servicing Segment — Variable Interest Entity, Measure of Activity, Income or Loss before Tax
$0

Other financials

Income statement

See full
Revenue$657.5M+1.6%
Gross profit$215.8M-0.3%
Operating income$84.6M-10.7%
Net income$66.3M-7.6%
EPS (diluted)$4.84-0.4%

Balance sheet

See full
Cash & equivalents$16.9M-90.3%
Total debt$236.9M+63.3%
Total equity$848.0M-28.2%
Total assets$1.5B-11.0%

Cash flow

See full
Operating cash flow$88.2M+169%
CapEx$17.1M+28.9%
Free cash flow$71.1M+265%

Valuation

See full
Market cap$5.79B-42.3%
Enterprise value$6.01B-39.6%
P/E22.3×-10.2×
P/S2.3×-1.8×

Profitability

See full
Gross margin32.4%-2.4pp
Operating margin12.9%-2.7pp
Net margin10.2%-2.2pp
FCF margin14.8%+2.2pp

Returns & leverage

See full
Return on equity25.6%-0.5pp
Debt / equity0.3×+0.2×
Current ratio0.9×-0.9×

Where this comes from

Reported directly by Chemed in its filing.

Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNet.

The official record: Chemed’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Chemed's segment vitas — interest income expense net.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Chemed's segment vitas — interest income expense net?
Chemed (CHE) reported segment vitas — interest income expense net of $6.24M in Q1 2026.
How has Chemed's segment vitas — interest income expense net changed year-over-year?
Chemed's segment vitas — interest income expense net increased by 17.8% year-over-year, from $5.3M to $6.24M.
What is the long-term trend for Chemed's segment vitas — interest income expense net?
Over 3 years (2022 to 2025), Chemed's segment vitas — interest income expense net has grown at a 5.9% compound annual growth rate (CAGR), from $18.9M to $22.45M.
What does segment vitas — interest income expense net mean?
This metric represents the net balance of interest income earned on cash and investments minus interest expenses paid on debt for the segment. It provides insight into the segment's net financial position and the impact of its treasury management activities on overall profitability.